247 related articles for article (PubMed ID: 28267793)
1. The DRF motif of CXCR6 as chemokine receptor adaptation to adhesion.
Koenen A; Babendreyer A; Schumacher J; Pasqualon T; Schwarz N; Seifert A; Deupi X; Ludwig A; Dreymueller D
PLoS One; 2017; 12(3):e0173486. PubMed ID: 28267793
[TBL] [Abstract][Full Text] [Related]
2. Homocysteine up-regulates vascular transmembrane chemokine CXCL16 and induces CXCR6+ lymphocyte recruitment in vitro and in vivo.
Postea O; Koenen RR; Hristov M; Weber C; Ludwig A
J Cell Mol Med; 2008; 12(5A):1700-9. PubMed ID: 18194461
[TBL] [Abstract][Full Text] [Related]
3. The chemokine receptor CXCR6 and its ligand CXCL16 are expressed in carcinomas and inhibit proliferation.
Meijer J; Ogink J; Kreike B; Nuyten D; de Visser KE; Roos E
Cancer Res; 2008 Jun; 68(12):4701-8. PubMed ID: 18559516
[TBL] [Abstract][Full Text] [Related]
4. Cell surface-anchored SR-PSOX/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6-expressing cells.
Shimaoka T; Nakayama T; Fukumoto N; Kume N; Takahashi S; Yamaguchi J; Minami M; Hayashida K; Kita T; Ohsumi J; Yoshie O; Yonehara S
J Leukoc Biol; 2004 Feb; 75(2):267-74. PubMed ID: 14634054
[TBL] [Abstract][Full Text] [Related]
5. Expression and regulation of the chemokine CXCL16 in Crohn's disease and models of intestinal inflammation.
Diegelmann J; Seiderer J; Niess JH; Haller D; Göke B; Reinecker HC; Brand S
Inflamm Bowel Dis; 2010 Nov; 16(11):1871-81. PubMed ID: 20848509
[TBL] [Abstract][Full Text] [Related]
6. Cutting edge: profile of chemokine receptor expression on human plasma cells accounts for their efficient recruitment to target tissues.
Nakayama T; Hieshima K; Izawa D; Tatsumi Y; Kanamaru A; Yoshie O
J Immunol; 2003 Feb; 170(3):1136-40. PubMed ID: 12538668
[TBL] [Abstract][Full Text] [Related]
7. The CXCL16 A181V mutation selectively inhibits monocyte adhesion to CXCR6 but is not associated with human coronary heart disease.
Petit SJ; Wise EL; Chambers JC; Sehmi J; Chayen NE; Kooner JS; Pease JE
Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):914-20. PubMed ID: 21233446
[TBL] [Abstract][Full Text] [Related]
8. Selectivity in the Use of Gi/o Proteins Is Determined by the DRF Motif in CXCR6 and Is Cell-Type Specific.
Singh SP; Foley JF; Zhang HH; Hurt DE; Richards JL; Smith CS; Liao F; Farber JM
Mol Pharmacol; 2015 Nov; 88(5):894-910. PubMed ID: 26316539
[TBL] [Abstract][Full Text] [Related]
9. Expression cloning of the STRL33/BONZO/TYMSTRligand reveals elements of CC, CXC, and CX3C chemokines.
Wilbanks A; Zondlo SC; Murphy K; Mak S; Soler D; Langdon P; Andrew DP; Wu L; Briskin M
J Immunol; 2001 Apr; 166(8):5145-54. PubMed ID: 11290797
[TBL] [Abstract][Full Text] [Related]
10. CXCR6/CXCL16 functions as a regulator in metastasis and progression of cancer.
Deng L; Chen N; Li Y; Zheng H; Lei Q
Biochim Biophys Acta; 2010 Aug; 1806(1):42-9. PubMed ID: 20122997
[TBL] [Abstract][Full Text] [Related]
11. Human gingival fibroblasts express functional chemokine receptor CXCR6.
Hosokawa Y; Hosokawa I; Ozaki K; Nakae H; Matsuo T
Clin Exp Immunol; 2009 Jun; 156(3):413-8. PubMed ID: 19438592
[TBL] [Abstract][Full Text] [Related]
12. Wnt5a-Ror2 signaling in mesenchymal stem cells promotes proliferation of gastric cancer cells by activating CXCL16-CXCR6 axis.
Takiguchi G; Nishita M; Kurita K; Kakeji Y; Minami Y
Cancer Sci; 2016 Mar; 107(3):290-7. PubMed ID: 26708384
[TBL] [Abstract][Full Text] [Related]
13. The Chemokine Receptor CXCR6 Evokes Reverse Signaling via the Transmembrane Chemokine CXCL16.
Adamski V; Mentlein R; Lucius R; Synowitz M; Held-Feindt J; Hattermann K
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28698473
[TBL] [Abstract][Full Text] [Related]
14. Escin suppresses migration and invasion involving the alteration of CXCL16/CXCR6 axis in human gastric adenocarcinoma AGS cells.
Lee HS; Hong JE; Kim EJ; Kim SH
Nutr Cancer; 2014; 66(6):938-45. PubMed ID: 24911042
[TBL] [Abstract][Full Text] [Related]
15. CXCR6-CXCL16 axis promotes prostate cancer by mediating cytoskeleton rearrangement via Ezrin activation and αvβ3 integrin clustering.
Singh R; Kapur N; Mir H; Singh N; Lillard JW; Singh S
Oncotarget; 2016 Feb; 7(6):7343-53. PubMed ID: 26799186
[TBL] [Abstract][Full Text] [Related]
16. Associations of CXCL16/CXCR6 with carotid atherosclerosis in patients with metabolic syndrome.
Lv Y; Hou X; Ti Y; Bu P
Clin Nutr; 2013 Oct; 32(5):849-54. PubMed ID: 23398954
[TBL] [Abstract][Full Text] [Related]
17. CXC chemokine ligand 16 promotes integrin-mediated adhesion of liver-infiltrating lymphocytes to cholangiocytes and hepatocytes within the inflamed human liver.
Heydtmann M; Lalor PF; Eksteen JA; Hübscher SG; Briskin M; Adams DH
J Immunol; 2005 Jan; 174(2):1055-62. PubMed ID: 15634930
[TBL] [Abstract][Full Text] [Related]
18. CXCL16/CXCR6 chemokine signaling mediates breast cancer progression by pERK1/2-dependent mechanisms.
Xiao G; Wang X; Wang J; Zu L; Cheng G; Hao M; Sun X; Xue Y; Lu J; Wang J
Oncotarget; 2015 Jun; 6(16):14165-78. PubMed ID: 25909173
[TBL] [Abstract][Full Text] [Related]
19. CXCL16/SR-PSOX is an interferon-gamma-regulated chemokine and scavenger receptor expressed in atherosclerotic lesions.
Wuttge DM; Zhou X; Sheikine Y; Wågsäter D; Stemme V; Hedin U; Stemme S; Hansson GK; Sirsjö A
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):750-5. PubMed ID: 14988089
[TBL] [Abstract][Full Text] [Related]
20. Chemokine axes CXCL12/CXCR4 and CXCL16/CXCR6 correlate with lymph node metastasis in epithelial ovarian carcinoma.
Guo L; Cui ZM; Zhang J; Huang Y
Chin J Cancer; 2011 May; 30(5):336-43. PubMed ID: 21527066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
